VIVS Valuation

VivoSim Labs Inc

Add to Watchlist

Advanced Chart

1.980

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

VIVS Relative Valuation

VIVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VIVS is overvalued; if below, it's undervalued.

Historical Valuation

VivoSim Labs Inc (VIVS) is now in the Overvalued zone, suggesting that its current forward PS ratio of 20.84 is considered Overvalued compared with the five-year average of -0.20. The fair price of VivoSim Labs Inc (VIVS) is between 1.11 to 1.55 according to relative valuation methord. Compared to the current price of 1.98 USD , VivoSim Labs Inc is Overvalued By 27.57%.

Relative Value

Fair Zone

1.11-1.55

Current Price：1.98

27.57%

Overvalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.34

P/B

Median3y

3.70

Median5y

3.70

-192.81

FCF Yield

Median3y

-274.79

Median5y

-274.79

Competitors Valuation Multiple

The average P/S ratio for VIVS's competitors is 4.73, providing a benchmark for relative valuation. VivoSim Labs Inc Corp (VIVS) exhibits a P/S ratio of 21.18, which is 348.13% above the industry average. Given its robust revenue growth of 75.86%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap